HKU scientists and microbiologists jointly discover a novel antiviral strategy for treatment of COVID-19 using…
Browsing: COVID-19
COVID-19, caused by the SARS-CoV-2 coronavirus, is a global infectious disease that emerged in late 2019 and reshaped public health, science, and society. It primarily affects the respiratory system but can impact multiple organs, leading to a wide range of symptoms from mild illness to severe complications. The pandemic spurred unprecedented scientific collaboration, driving rapid advances in virology, epidemiology, and vaccine development, including mRNA technology. Research into COVID-19 continues to reveal insights into viral evolution, immune response, long COVID, and pandemic preparedness. Its legacy continues to influence healthcare systems, global health policy, and biomedical innovation worldwide.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of…
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen…
While most COVID-19 cases are asymptomatic or mild, severe complications associated with acute respiratory distress…
Why are some people more resilient to viruses than others? The answer has eluded scientists…
Coronavirus uses enzymatic cutter for virus production and to disable essential immune proteins. American and…
Blocking Immune System Pathway May Stop COVID-19 Infection, Prevent Severe Organ Damage While the world…
Test could inform doctors on best treatment options. Scientists have developed, for the first time,…
Countries with international travel restrictions suffered fewer COVID-19 fatalities. Travel restrictions implemented early on in…
The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate…
In the absence of approved, effective treatments for COVID-19, some hospitals have been treating patients…
New light is being shed on a little-known role of Y chromosome genes, specific to…
Model developed by Brazilian researchers predicts spatial and temporal evolution of epidemic diseases and can…
In a new COVID-19 clinical trial, UC Davis Health tests the same REGN-COV2 antibody combination…
Individuals with blood type O may have lowest risk of infection; individuals with A and…
In this study, which was recently published in the journal Frontiers in Immunology, researchers used…
One of the most significant questions about the novel coronavirus is whether people who are…
Scientists in the US and UK publish first in-depth look at how CD4+ T cells…